Trials / Completed
CompletedNCT04914520
Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects
A Phase 1 Study to Assess the Safety, Tolerability, and Immunogenicity of VN-0200 After Intramuscular Injections in Japanese Healthy Adults and Elderly Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Daiichi Sankyo Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the safety, tolerability, and immunogenicity of VN-0200 after intramuscular injections in Japanese healthy adults and elderly subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | VN-0200 | VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total |
| BIOLOGICAL | Placebo | Placebo administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total |
Timeline
- Start date
- 2021-06-11
- Primary completion
- 2021-12-16
- Completion
- 2021-12-16
- First posted
- 2021-06-04
- Last updated
- 2021-12-22
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04914520. Inclusion in this directory is not an endorsement.